SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?


To: david james who wrote (875)4/18/2000 5:59:00 PM
From: Bosco  Respond to of 1298
 
Hi Jack & all - 1st, hope everyone is hanging tough. But remember, great fortune and great losses are only money, please don't forget to live life by worrying too much about the market!

Jack, thx for the write up. While most of it is a repeat, and regulars here know about it --- and has debated about it at length previously :) --- it is a good recap for the newcomers [if there are newcomers <VBG>!]

Since I am investing in CEGE for the long term, barring any new development that may alter my view of CEGE, I am not too worried about repeating the p/e mantra. One should be mindful that having a low p/e [good in this case for CEGE] may actually scare off a lot of *growth* investors. Yes, I still see CEGE as a super growth stock, albeit it has great fundamentals too! The minute people tell me CEGE has only cash and no growth, it is the time for me to sell. Just my personal preference, of course.

best, Bosco



To: david james who wrote (875)4/18/2000 6:31:00 PM
From: mts362  Read Replies (1) | Respond to of 1298
 
>>The company should have a P/E of around 5 following earnings

If you count the gain from ABGX sale, which any analyst would tell you is wrong.

MTS